Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,526 | 75 | 93.9% |
| Education | $99.99 | 1 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $585.64 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $206.12 | 7 | $0 (2024) |
| GENZYME CORPORATION | $194.38 | 8 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $160.25 | 10 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $147.93 | 8 | $0 (2023) |
| Amgen Inc. | $103.03 | 4 | $0 (2024) |
| PFIZER INC. | $72.74 | 3 | $0 (2023) |
| Lilly USA, LLC | $59.46 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $42.30 | 2 | $0 (2024) |
| Stemline Therapeutics Inc. | $20.05 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $258.17 | 8 | Janssen Biotech, Inc. ($121.11) |
| 2023 | $208.50 | 10 | PFIZER INC. ($72.74) |
| 2022 | $334.70 | 15 | Sun Pharmaceutical Industries Inc. ($81.79) |
| 2021 | $385.62 | 19 | AbbVie Inc. ($229.57) |
| 2020 | $439.49 | 24 | AbbVie Inc. ($262.66) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Immunology | ||||||
| 04/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 03/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Immunology | ||||||
| 01/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: Inflammation | ||||||
| 05/03/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.01 | General |
| 04/07/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Inflammation | ||||||
| 04/07/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Dermatology | ||||||
| 03/22/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Inflammation & Immunology | ||||||
| 03/02/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: DERMATOLOGY | ||||||
| 02/28/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: Inflammation | ||||||
| 02/07/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Inflammation | ||||||
| 01/31/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Immunology | ||||||
| 01/27/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: DERMATOLOGY | ||||||
| 01/19/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Dermatology | ||||||
| 12/13/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Dermatology | ||||||
| 11/29/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Dermatology | ||||||
| 11/16/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: Immunology | ||||||
| 11/14/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Immunology | ||||||
| 11/10/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Dermatology | ||||||
| 10/20/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Immunology | ||||||
| 09/21/2022 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,191 | 5,559 | $942,052 | $215,614 |
| 2022 | 20 | 2,788 | 4,691 | $779,130 | $178,402 |
| 2021 | 18 | 2,508 | 4,197 | $653,685 | $152,347 |
| 2020 | 19 | 2,736 | 4,545 | $682,691 | $159,388 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,397 | 2,519 | $272,811 | $69,338 | 25.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 98 | 124 | $111,461 | $28,301 | 25.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 235 | 285 | $85,454 | $18,874 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 262 | $69,643 | $15,033 | 21.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 88 | 114 | $82,456 | $11,042 | 13.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 114 | 224 | $33,291 | $8,675 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 91 | $34,256 | $8,548 | 25.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 68 | 75 | $37,413 | $8,341 | 22.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 72 | 88 | $29,509 | $7,331 | 24.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 171 | 222 | $43,962 | $7,223 | 16.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 45 | $23,749 | $5,490 | 23.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 127 | 886 | $17,453 | $4,495 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $18,134 | $3,987 | 22.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 98 | 176 | $14,468 | $3,815 | 26.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $11,941 | $3,194 | 26.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 105 | 113 | $11,448 | $3,050 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $10,788 | $2,228 | 20.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 50 | $8,314 | $2,003 | 24.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 69 | 99 | $7,640 | $1,821 | 23.8% |
| 69100 | Biopsy of ear | Office | 2023 | 24 | 27 | $7,718 | $1,262 | 16.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $8,230 | $1,101 | 13.4% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 54 | 58 | $1,913 | $462.19 | 24.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,417 | 2,399 | $265,709 | $67,841 | 25.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 87 | 105 | $95,380 | $24,901 | 26.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 177 | 227 | $69,327 | $14,112 | 20.4% |
About Thomas Lee
Thomas Lee is a Dermatopathology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2015. The National Provider Identifier (NPI) number assigned to this provider is 1396122727.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Lee has received a total of $1,626 in payments from pharmaceutical and medical device companies, with $258.17 received in 2024. These payments were reported across 76 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,526).
As a Medicare-enrolled provider, Lee has provided services to 11,223 Medicare beneficiaries, totaling 18,992 services with total Medicare billing of $705,751. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Phoenix, AZ
- Active Since 05/06/2015
- Last Updated 03/20/2023
- Taxonomy Code 207ZD0900X
- Entity Type Individual
- NPI Number 1396122727
Products in Payments
- SKYRIZI (Biological) $269.67
- HUMIRA (Biological) $261.49
- DUPIXENT (Biological) $205.23
- DUOBRII (Drug) $126.51
- TREMFYA (Drug) $121.11
- Winlevi (Drug) $113.65
- REMICADE (Biological) $85.01
- Enbrel (Biological) $68.82
- RINVOQ (Biological) $54.48
- EUCRISA (Drug) $51.77
- OLUMIANT (Drug) $40.98
- Absorica LD (Drug) $34.28
- Otezla (Drug) $34.21
- LIBTAYO (Biological) $31.45
- CIBINQO (Drug) $20.97
- ELZONRIS (Drug) $20.05
- TALTZ (Drug) $18.48
- JUBLIA (Drug) $17.39
- ARAZLO (Drug) $16.35
- POTELIGEO (Drug) $15.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Phoenix
Dr. Toni Stockton, M.d, M.D
Dermatopathology — Payments: $30,222
Iftikhar Ahmed, M.d, M.D
Dermatopathology — Payments: $1,427
Dr. Yebabe Mengesha, Md, MD
Dermatopathology — Payments: $889.68
Dr. Chen Wang, M.d, M.D
Dermatopathology — Payments: $315.56
Dr. Maria Alzona, Md, MD
Dermatopathology — Payments: $113.39
Dr. Eugene Dulaney, Md, MD
Dermatopathology